SA awards Cipla R345m respiratory contract

Comment on this story


Cipla111

inlsa

Cipla Medpro. Photo: Supplied.

Cape Town - South Africa has awarded Cipla Medpro a 345 million rand share in the national respiratory tender as Africa's most advanced economy seeks to cut high asthma mortality rates, the company said on Thursday.

“In South Africa, asthma is the third most common cause of hospital admissions of children, yet only two percent of asthmatics receive treatment,” chief executive Paul Miller said in a statement.

South Africa has the world's fourth highest asthma death rate among 5-35 year olds, with thousands dying each year from a disease which causes shortness of breathe, wheezing and coughing, according to the Global Initiative for Asthma,

The contract runs from the beginning of next month to April 30, 2017 and will see South Africa's third largest pharmaceutical company providing asthma medication. - Reuters


sign up
 
 

Comment Guidelines



  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

     

Join us on

IOL-Social networks IOL-Social networks IOL-Social networks IOL-Social networks